Systems medicine advances in interstitial lung disease
Fibrotic lung diseases involve subject–environment interactions, together with dysregulated homeostatic processes, impaired DNA repair and distorted immune functions. Systems medicine-based approaches are used to analyse diseases in a holistic manner, by integrating systems biology platforms along w...
Main Authors: | Flavia R. Greiffo, Oliver Eickelberg, Isis E. Fernandez |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2017-09-01
|
Series: | European Respiratory Review |
Online Access: | http://err.ersjournals.com/content/26/145/170021.full |
Similar Items
-
Personalised medicine in interstitial lung diseases
by: Maria A. Kokosi, et al.
Published: (2018-04-01) -
Interstitial lung disease in systemic sclerosis
by: E.A. Renzoni
Published: (2016-02-01) -
Advanced interstitial lung fibrosis with emphysema and pulmonary hypertension with no evidence for interstitial lung disease on high resolution CT
by: Vasile Foris, et al.
Published: (2019-07-01) -
Levetiracetam-induced interstitial lung disease in a patient with advanced lung cancer
by: Shintaro Sato, et al.
Published: (2020-01-01) -
Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD)
by: Padmini Khedoe, et al.
Published: (2020-09-01)